TECTONIC THERAPEUTIC, INC. Deferred Tax Assets, Net of Valuation Allowance
TECTONIC THERAPEUTIC, INC. (TECX) had Deferred Tax Assets, Net of Valuation Allowance of $630.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $630.00K.
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.09M.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.94M; Deferred Tax Assets, Net of Valuation Allowance as first filed $118.00K.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $320.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $630.00K 10-K · filed 2026-02-26 | |
| 2024-12-31 | $1.09M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $1.94M 10-K · filed 2025-03-20 | $118.00K 10-K · filed 2024-03-14 |
| 2022-12-31 | $320.00K 10-K · filed 2024-03-14 | |
| 2021-12-31 | $107.00K 10-K · filed 2023-03-23 | |
| 2020-12-31 | $160.00K 10-K · filed 2022-03-17 | |
| 2019-12-31 | $209.00K 10-K · filed 2021-03-18 | |
| 2018-12-31 | $238.00K 10-K · filed 2020-03-16 | |
| 2017-12-31 | $20.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |